faq

The compounded weight loss medications offered by Moongate Medical are prepared by licensed pharmaceutical professionals and sourced from FDA-registered or accredited compounding pharmacies. This means they must adhere to stringent quality and safety control standards. Compounded semaglutide and tirzepatide are designed to meet individual patient weight loss needs.

Semaglutide and tirzepatide are FDA-approved for long-term weight loss treatment and considered safe when administered as part of a medically monitored weight loss program. Some common side effects patients may experience while taking these medications include nausea, diarrhea, or constipation. Adjusting your dosage often improves these side effects. We do not recommend semaglutide or tirzepatide injections for weight management if you are breastfeeding or have a preexisting kidney or liver condition.

Your first subcutaneous injection will be administered either during your initial in-person consultation with Nurse Practitioner Melody or sent to your home with detailed instructions on how to injection yourself.  You will receive training and supplies for self-injections administered once weekly at home over 4 months. We gradually increase dosage throughout your treatment program to minimize side effects.

While results vary for each patient, most men and women observe weight loss in the first month of treatment and notice significant results in 4 to 6 months.

Every patient is unique, but most patients taking semaglutide or tirzepatide lose approximately 20% of their body weight.

Research shows that most patients regain some weight after stopping treatment. To preserve your weight loss, it’s essential to maintain healthy lifestyle habits such as eating a balanced diet and working out regularly.